Prevention and Treatment of Radiation Skin Reactions

Mepitel Film for preventing skin reactions in radiotherapy

Believe It

We believe Mepitel® Film is the solution for preventing radiotherapy skin reactions

PREVENTION

“Skin reactions can seriously affect the quality of life of cancer patients during radiation therapy. Our research shows that there are ways to significantly reduce the severity of these reactions”Dr Patries HerstSenior lecturer in the Department of Radiation Therapy at the Medical School of the University of Otago in Wellington, New Zealand.

We also believe the figures speak for themselves:

One in eight women will be diagnosed with breast cancer,

Up to 90% of those undergoing radiotherapy will develop skin reactions as a side effect.

We believe Mepitel® Film is the solution for preventing radiotherapy skin reactions

Reactions can be very painful, affecting these patients’ quality of life. Skin reactions related to radiotherapy usually appear within 1-4 weeks of the start of treatment, persist for the duration of the therapy and may require 2–4 weeks to heal after treatment is complete. Severity of skin reactions ranges from from mild erythema to ulceration and severe moist desquamation.

Believe the evidence

A randomized controlled clinical trial1 published in 2014, showed that the prophylactic use of Mepitel® Film decreased the severity of radiotherapy skin reactions by 92%, and completely prevented moist desquamation.

How prevention works

The key to preventing skin reactions is to use a protective film dressing on the skin from the first day of radiotherapy, protecting fragile skin from moisture and the daily friction of clothing.

Continued use of Mepitel® Film for 2 to 4 weeks after radiotherapy treatment has stopped is clinically proven to be highly effective at preventing skin reactions, allowing skin to heal and recover undisturbed.

When Mepitel® Film is used in this way, as part of radiotherapy, it is clinically proven to be highly effective at preventing skin reactions.

We believe Mepilex® Lite is the solution for treating radiotherapy skin reactions

A randomized controlled clinical trial published in 2012 has shown that:

Mepilex® Lite reduces the severity of radiation by 41% when compared with aqueous creams2.

80% of the patients participating in the study said they preferred the Mepilex® Lite dressings over the cream.

Benefits you can believe in

Mepilex® Lite is a thin and gentle absorbent foam dressing with Safetac®, which is used in the critical period 2-4 weeks after radiotherapy treatment has stopped. It protects fragile skin from the daily friction of clothes and moisture, allowing it to heal undisturbed and recover from treatment.

Superior comfortMepilex® Lite is thin, soft and conforms well to body contours, such as breasts, and is very comfortable to wear.

Skin-friendly Safetac®Our patented technology gently adheres to the skin, but doesn’t cause trauma to moist wounds and surrounding areas, minimizing pain and stress when the dressing is removed.

Ease of useMepilex® Lite is easy to handle, and can be cut to ensure a perfect fit for irregular shaped areas.

Proven efficacy for treatment of radiotherapy-induced skin reactions.Mepilex® Lite is a thin, highly comformable dressing with Safetac® technology. It is very easy to work with and ideal for hard-to-dress areas. Mepilex® Lite is clinically proven to reduce the severity of radiation-induced skin reactions2.

Mölnlycke is a world-leading medical products and solutions company that equips healthcare professionals to achieve the best patient, clinical and economic outcomes.

We use cookies to improve your use and experience of Mölnlycke’s websites. By continuing to browse Mölnlycke’s site(s), you consent to the use of cookies in accordance with Mölnlycke’s applicable policies.

We design and supply medical solutions to enhance performance in healthcare. We have representatives worldwide – you're welcome to talk to one of our sales teams or agents, or book a visit. Contact us.